COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,083 Articles (21,556 medRxiv, 7,527 bioRxiv)

Most recent first Previous |  Page 2673: Articles 26721-26730  | Next

Heparin-induced thrombocytopenia is associated with a high risk of mortality in critical COVID-19 patients receiving heparin-involved treatment
Liu, X., Zhang, X., Xiao, Y., Gao, T., Wang, G., Wang, Z., Zhang, Z., Hu, Y., Dong, Q., Zhao, S., Yu, L., Zhang, S., Li, H., Li, K., Chen, W., Bian, X., Mao, Q., Cao, C.
10.1101/2020.04.23.20076851 — Posted: 2020-04-28
Vitamin D Insufficiency is Prevalent in Severe COVID-19
Lau, F. H., Majumder, R., Torabi, R., Saeg, F., Hoffman, R., Cirillo, J. D., Greiffenstein, P.
10.1101/2020.04.24.20075838 — Posted: 2020-04-28 Discussion: Onsite
Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol
Docherty, A. B., Harrison, E. M., Green, C. A., Hardwick, H. E., Pius, R., Norman, L., Holden, K. A., Read, J. M., Dondelinger, F., Carson, G., Merson, L., Lee, J., Plotkin, D., Sigfrid, L., Halpin, S., Jackson, C., Gamble, C., Horby, P. W., Nguyen-Van-Tam, J. S., Dunning, J., Openshaw, P. J., Baillie, J. K., Semple, M. G.
10.1101/2020.04.23.20076042 — Posted: 2020-04-28 Discussion: Onsite
Pharmacokinetic bases of the hydroxychloroquine response in COVID-19: implications for therapy and prevention
Savarino, A., Tarek, M.
10.1101/2020.04.23.20076471 — Posted: 2020-04-28
The effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on death and severity of disease in patients with coronavirus disease 2019 (COVID-19): A meta-analysis
GHOSAL, S., Mukherjee, J. J., Sinha, B., Gangopadhyay, K. K.
10.1101/2020.04.23.20076661 — Posted: 2020-04-28
SARS-CoV-2 Detection Using an Isothermal Amplification Reaction and a Rapid, Inexpensive Protocol for Sample Inactivation and Purification
Rabe, B. A., Cepko, C.
10.1101/2020.04.23.20076877 — Posted: 2020-04-28
Comparison of SARS-CoV-2 Exit Strategies Building Blocks
Barkan, E., Shilo, S., Talmor-Barkan, Y.
10.1101/2020.04.23.20072850 — Posted: 2020-04-28
Predictors of adherence to public health instructions during the COVID-19 pandemic
Pollak, Y., Dayan, H., Shoham, R., Berger, I.
10.1101/2020.04.24.20076620 — Posted: 2020-04-28
Multi-chain Fudan-CCDC model for COVID-19 in Iran
Pan, H., Shao, N., Yan, Y., Luo, X., Ahmadi, A., Fadaei, Y., Cheng, J., Chen, W.
10.1101/2020.04.22.20075630 — Posted: 2020-04-28
COVID-19 spreading: a model
Ilyin, S. O.
10.1101/2020.04.23.20076562 — Posted: 2020-04-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).